GlaxoSmithKline's ViiV Healthcare Wins First FDA OK for Two-Drug HIV Regimen Post author:Sam Post published:November 21, 2017 Post category:BioPharma HIV patients have a new maintenance drug in their arsenal of medication. Source: BioSpace You Might Also Like Incoming Novartis CEO, Bayer Leader Join President Trump for Private Dinner at Davos January 25, 2018 New Jersey Implant Maker Braeburn Pharma Yanks Plans for $150 Million IPO February 2, 2017 BioTime To Announce Second Quarter 2017 Results On August 2, 2017 July 19, 2017
Incoming Novartis CEO, Bayer Leader Join President Trump for Private Dinner at Davos January 25, 2018
